Event Registration - American Society for Pain Management Nurses
Ketamine in the Outpatient population
1/1/2025 - 1/31/2030Event Description
Session Description: This is an on demand presentation detailing oral ketamine use in the hospice setting.
Session Abstract: Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist which has traditionally been utilized as a general, dissociative anesthetic, indicated for short diagnostic and surgical procedures. The NMDA receptor is in a calcium channel closely involved in the development of central (dorsal horn) desensitization. This channel has a role in opioid resistant pain, neuropathic pain, allodynia and hyperalgesia. During this power session, we will examine its role in pain management in the hospice setting for one adult case and one pediatric case. We will examine Ketamine’s role in persistent pain, it’s efficacy, implication for clinical practice, side effects and nurse protocol monitoring. We will discuss future implications or outpatient use of oral Ketamine in patients with persistent pain.
Session Abstract: Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist which has traditionally been utilized as a general, dissociative anesthetic, indicated for short diagnostic and surgical procedures. The NMDA receptor is in a calcium channel closely involved in the development of central (dorsal horn) desensitization. This channel has a role in opioid resistant pain, neuropathic pain, allodynia and hyperalgesia. During this power session, we will examine its role in pain management in the hospice setting for one adult case and one pediatric case. We will examine Ketamine’s role in persistent pain, it’s efficacy, implication for clinical practice, side effects and nurse protocol monitoring. We will discuss future implications or outpatient use of oral Ketamine in patients with persistent pain.